73 related articles for article (PubMed ID: 11834890)
21. Ex vivo and in vivo alpha1-adrenoceptor binding characteristics of a novel alpha1L-adrenoceptor antagonist, JTH-601, in rat tissues.
Ohkura T; Yamada S; Tohma A; Kimura R; Aisaka K
Biol Pharm Bull; 1999 Jul; 22(7):687-90. PubMed ID: 10443463
[TBL] [Abstract][Full Text] [Related]
22. RS-17053 (N-[2-(2-cyclopropylmethoxyphenoxy)ethyl]-5-chloro-alpha, alpha-dimethyl-1H-indole-3-ethanamine hydrochloride), a selective alpha 1A-adrenoceptor antagonist, displays low affinity for functional alpha 1-adrenoceptors in human prostate: implications for adrenoceptor classification.
Ford AP; Arredondo NF; Blue DR; Bonhaus DW; Jasper J; Kava MS; Lesnick J; Pfister JR; Shieh IA; Vimont RL; Williams TJ; McNeal JE; Stamey TA; Clarke DE
Mol Pharmacol; 1996 Feb; 49(2):209-15. PubMed ID: 8632751
[TBL] [Abstract][Full Text] [Related]
23. In vivo measurement by [3H]Tamsulosin of alpha1 adrenoceptors in rat tissues in relation to the pharmacokinetics.
Yamada S; Ohkura T; Deguchi Y; Kimura R
J Pharmacol Exp Ther; 1999 Jun; 289(3):1575-83. PubMed ID: 10336555
[TBL] [Abstract][Full Text] [Related]
24. Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia.
Tatemichi S; Tomiyama Y; Maruyama I; Kobayashi S; Kobayashi K; Maezawa A; Kobayashi M; Yamazaki Y; Shibata N
Neurourol Urodyn; 2006; 25(7):792-9; discussion 800-1. PubMed ID: 16894620
[TBL] [Abstract][Full Text] [Related]
25. KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues.
Shibata K; Foglar R; Horie K; Obika K; Sakamoto A; Ogawa S; Tsujimoto G
Mol Pharmacol; 1995 Aug; 48(2):250-8. PubMed ID: 7651358
[TBL] [Abstract][Full Text] [Related]
26. Effects of α1-adrenoceptor antagonists on phenylephrine-induced salivary secretion and intraurethral pressure elevation in anesthetized rats.
Yanai-Inamura H; Ohtake A; Noguchi Y; Hatanaka T; Suzuki M; Ueshima K; Sato S; Sasamata M
Eur J Pharmacol; 2012 Mar; 679(1-3):127-31. PubMed ID: 22314219
[TBL] [Abstract][Full Text] [Related]
27. Effects of castration on contraction and alpha(1)-adrenoceptor expression in rat prostate.
Homma Y; Hamada K; Nakayama Y; Tsujimoto G; Kawabe K
Br J Pharmacol; 2000 Dec; 131(7):1454-60. PubMed ID: 11090120
[TBL] [Abstract][Full Text] [Related]
28. Z-350, a novel compound with alpha 1-adrenoceptor antagonistic and steroid 5 alpha-reductase inhibitory actions: pharmacological properties in vivo.
Fukuta Y; Fukuda Y; Higashino R; Yoshida K; Ogishima M; Tamaki H; Takei M
J Pharmacol Exp Ther; 1999 Sep; 290(3):1013-8. PubMed ID: 10454472
[TBL] [Abstract][Full Text] [Related]
29. A selective alpha1A-adrenoceptor antagonist inhibits detrusor overactivity in a rat model of benign prostatic hyperplasia.
Tatemichi S; Akiyama K; Kobayashi M; Yamazaki Y; Yokoyama O; Uruno T
J Urol; 2006 Sep; 176(3):1236-41. PubMed ID: 16890732
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of buflomedil on prostate alpha1A adrenoceptor in the Wistar rat.
Tang LM; Cheng JT; Tong YC
Neurosci Lett; 2004 Sep; 367(2):224-7. PubMed ID: 15331158
[TBL] [Abstract][Full Text] [Related]
31. Effects of silodosin and tamsulosin on the urethra and cardiovascular system in young and old dogs with benign prostatic hyperplasia.
Kobayashi S; Tomiyama Y; Tatemichi S; Hoyano Y; Kobayashi M; Yamazaki Y
Eur J Pharmacol; 2009 Jun; 613(1-3):135-40. PubMed ID: 19389393
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of the uroselective alpha-1 antagonist Rec 15/2739 (SB 216469): role of the alpha-1L adrenoceptor in tissue selectivity, part I.
Leonardi A; Hieble JP; Guarneri L; Naselsky DP; Poggesi E; Sironi G; Sulpizio AC; Testa R
J Pharmacol Exp Ther; 1997 Jun; 281(3):1272-83. PubMed ID: 9190863
[TBL] [Abstract][Full Text] [Related]
33. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
Hussain MB; Marshall I
Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of novel alpha1a adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia.
Nagarathnam D; Wetzel JM; Miao SW; Marzabadi MR; Chiu G; Wong WC; Hong X; Fang J; Forray C; Branchek TA; Heydorn WE; Chang RS; Broten T; Schorn TW; Gluchowski C
J Med Chem; 1998 Dec; 41(26):5320-33. PubMed ID: 9857099
[TBL] [Abstract][Full Text] [Related]
35. Effect of 4-chloro-7-trifluoromethyl-10H-benzo[4,5]furo[3,2-b]indole-1-carboxylic acid on the intraurethral pressure in a rat model of benign prostatic hyperplasia.
Choi BR; Soni KK; Zhang LT; Lee SW; So I; Kim HK; Park JK
Int J Urol; 2016 Mar; 23(3):259-65. PubMed ID: 26646436
[TBL] [Abstract][Full Text] [Related]
36. Pharmacologic characterization of CHIR 2279, an N-substituted glycine peptoid with high-affinity binding for alpha 1-adrenoceptors.
Gibbons JA; Hancock AA; Vitt CR; Knepper S; Buckner SA; Brune ME; Milicic I; Kerwin JF; Richter LS; Taylor EW; Spear KL; Zuckermann RN; Spellmeyer DC; Braeckman RA; Moos WH
J Pharmacol Exp Ther; 1996 May; 277(2):885-99. PubMed ID: 8627571
[TBL] [Abstract][Full Text] [Related]
37. New Multi-target Antagonists of α1A-, α1D-Adrenoceptors and 5-HT1A Receptors Reduce Human Hyperplastic Prostate Cell Growth and the Increase of Intraurethral Pressure.
Nascimento-Viana JB; Carvalho AR; Nasciutti LE; Alcántara-Hernández R; Chagas-Silva F; Souza PA; Romeiro LA; García-Sáinz JA; Noël F; Silva CL
J Pharmacol Exp Ther; 2016 Jan; 356(1):212-22. PubMed ID: 26493747
[TBL] [Abstract][Full Text] [Related]
38. A-61603, a potent alpha 1-adrenergic receptor agonist, selective for the alpha 1A receptor subtype.
Knepper SM; Buckner SA; Brune ME; DeBernardis JF; Meyer MD; Hancock AA
J Pharmacol Exp Ther; 1995 Jul; 274(1):97-103. PubMed ID: 7616455
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of alpha1-adrenoceptors in the rabbit iris: pharmacological characterization and expression of mRNA.
Nakamura S; Taniguchi T; Suzuki F; Akagi Y; Muramatsu I
Br J Pharmacol; 1999 Jul; 127(6):1367-74. PubMed ID: 10455286
[TBL] [Abstract][Full Text] [Related]
40. Prostate selectivity of JTH-601-G1, an active metabolite of JTH-601, in dogs.
Suzuki Y; Kanada A; Okaya Y; Kurahashi Y; Kogayu M; Kobayashi T; Aisaka K
BJU Int; 2000 Mar; 85(4):542-50. PubMed ID: 10691841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
